How Glenmark convinced its investors to back its high-risk R&D strategy
While earlier attempts were unsuccessful, with Glenmark running into huge losses, there seems to be growing consensus that the drugmaker’s R&D strategy makes it a different company. Perhaps even a valuable one.
11 February, 2025•10 min
0
11 February, 2025•10 min
0
More in Business
Business
UAE conglomerates set their sights on India
A series of new investments earmarked for India, good and bad news from Saudi Arabia and AI deals at Davos, among other updates.
You may also like
Chaos
India needs to stop courting the US and look for a solid plan B
It’s never a good sign when your foreign minister needs a lobbyist to meet US officials. The recent events signal a breakdown in the Modi government’s ability to operate in today’s Washington through its own machinery.
Business
The 72 hours that saw IndiGo unravel
A crew crunch, new regulatory norms and simmering discontent push India’s biggest airline into its biggest crisis yet, one that could seriously dent its reputation for reliability.
Business
India takes an unapologetic stand at COP30
As talks harden, India drags finance and fairness into the conversation at the annual climate summit.